Key result
Cyproheptadine and bromocriptine resolve symptoms in a patient with coexisting serotonin and neuroleptic malignant syndromes.
Why the study?
The coexistence of serotonin syndrome and neuroleptic malignant syndrome in patients receiving both serotonergic agents and neuroleptics is unclear and requires diagnostic and therapeutic clarification.
Case Report (n=1)
This case highlights the rare but possible coexistence of serotonin syndrome and neuroleptic malignant syndrome in patients receiving both serotonergic and neuroleptic medications, requiring a combined therapeutic approach.
No takes yet. Share an insight, caveat, or question.
May guide dual therapy in rare overlapping cases; hypothesis-generating and requires prospective validation.
Prakash et al. (2021) conducted a case report in Serotonin syndrome and neuroleptic malignant syndrome (n=1). Cyproheptadine and bromocriptine was evaluated on Resolution of symptoms. Treatment with cyproheptadine and bromocriptine provided complete resolution of symptoms in a patient with coexisting serotonin syndrome and neuroleptic malignant syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: